|
|
Taiwan Academic Institutional Repository >
Browse by Author
|
"yang chih hsin"
Showing items 41-65 of 115 (5 Page(s) Totally)
<< < 1 2 3 4 5 > >>
View [10|25|50] records per page
| 國立成功大學 |
2009-09 |
BIBW 2992, a novel irreversible EGFR/HER2 tyrosine kinase inhibitor, in chemonaive patients with adenocarcinoma of the lung and activating EGFR mutations
|
Yang Chih-Hsin; Shih Jin-Yuan; Su Wu-Chou; Hsia Te-Chun; Ho Ching-Liang; Dudek, Arkadiusz Z.; Terlizzi, Elizabeth; Zhao Yihua M; Shahidi, Mehdi; Miller, Vincent A. |
| 國立臺灣大學 |
2009 |
Bibw 2992, a Novel Irreversible Egfr/Her2 Tyrosine Kinase Inhibitor, in Chemonaive Patients with Adenocarcinoma of the Lung and Activating Egfr Mutations
|
楊志新; 施金元; 蘇五洲; 夏德椿; YANG, CHIH-HSIN; SHIH, JIN-YUAN; SU, WU- CHOU; HSIA, TE-CHUN |
| 國立臺灣大學 |
2009 |
Clinical Outcomes of Patients with Epidermal Growth Factor Receptor (Egfr ) Mutations (Mut) in Ipass (Iressatm Pan Asia Study)
|
趙祖怡; 楊志新; CHAO, TSU-YI; YANG, CHIH-HSIN |
| 國立臺灣大學 |
2009 |
Vandetanib Plus Pernetrexed Versus Pemetrexed as 2nd-Line Therapy in Patients with Advanced Nsclc: A Randomized, Double-Blind Phase Iii Trial ( Zeal)
|
楊志新; YANG, CHIH-HSIN |
| 國立臺灣大學 |
2009 |
An Open-Label Single-Arm Phase Iv Study of Pemetrexed in Taiwanese Patients with Advanced Non-Small Cell Lung Cancer Who Have Had Prior Chemotherapy
|
張基晟; 蔡俊明; 夏德椿; 楊志新; CHANG, GEE-CHEN; TSAI, CHUN-MING; HSIA, TE-CHUN; YANG, CHIH-HSIN |
| 國立臺灣大學 |
2009 |
Vandetanib Plus Pemetrexed Vs Pemetrexed as 2nd-Line Therapy in Patients with Advanced Non-Small-Cell Lung Cancer (Nsclc); a Randomized, Double- Blind Phase Iii Trial
|
楊志新; YANG, CHIH-HSIN |
| 國立臺灣大學 |
2009 |
Gefitinib or Carboplatin-Paclitaxel in Pulmonary Adenocarcinoma
|
楊志新; YANG, CHIH-HSIN |
| 國立臺灣大學 |
2009 |
Melatonin Inhibits Arsenite-Induced Peripheral Neurotoxicity
|
林滿玉; 范素芬; 趙珮玲; 楊志新; LIN, A. MAAN-YUH; FANG, SU-FEN; CHAO, PEI -LING; YANG, CHIH-HSIN |
| 國立臺灣大學 |
2009 |
First-Line Systemic Treatment of Advanced Stage Non-Small-Cell Lung Cancer in Asia: Consensus Statement from the Asian Oncology Summit 2009
|
楊志新; YANG, CHIH-HSIN |
| 國立臺灣大學 |
2009 |
Comparison of Epidermal Growth Factor Receptor Mutations between Primary and Corresponding Metastatic Tumors in Tyrosine Kinase Inhibitor-Naive Non -Small-Cell Lung Cancer
|
高劍虹; 張逸良; 蔡孟峰; 吳振都; 余忠仁; 楊志新; 李元麒; 楊泮池; 施金元; GOW, CHIEN-HUNG; CHANG, YIH-LEONG; TSAI, MENG-FENG; WU, CHEN-TU; YU, CHONG-JEN; YANG, CHIH-HSIN; LEE, YUNG-CHIE; YANG, PAN-CHYR; SHIH, JIN-YUAN |
| 國立臺灣大學 |
2009 |
Egfr Intron 1 Dinucleotide Repeat Polymorphism Is Associated with the Occurrence of Skin Rash with Gefitinib Treatment
|
黃敬倫; 楊志新; 葉坤輝; 胡賦强; 陳冠宇; 施金元; 林宗哲; 余忠仁; 鄭安理; 楊泮池; HUANG, CHING-LUN; YANG, CHIH-HSIN; YEH, KUN-HUEI; HU, FU-CHANG; CHEN, KUAN-YU; SHIH, JIN-YUAN; LIN, ZONG-ZHE; YU, CHONG-JEN; CHENG, ANN-LII; YANG, PAN-CHYR |
| 國立臺灣大學 |
2009 |
Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Elderly or Poor Performance Status Patients with Advanced Non-Small Cell Lung Cancer
|
林家齊; 楊志新; LIN, CHIA-CHI; YANG, CHIH-HSIN |
| 國立臺灣大學 |
2009 |
National Center of Excellence for Clinical Trials and Research at National Taiwan University Hospital
|
林家齊; 楊志新; 鄭安理; 陳榮楷; 何弘能; LIN, CHIA-CHI; YANG, CHIH-HSIN; CHENG, ANN-LII; CHAN, WING-KAI; HO, HONG-NERNG |
| 國立臺灣大學 |
2009 |
Quality of Life in Advanced Non-Small Cell Lung Cancer Patients Receiving First-Line Gefitinib Monotherapy
|
邵幼雲; 林宗哲; 胡賦强; 余忠仁; 施金元; 胡文郁; 張逸良; 鄭安理; 楊泮池; 楊志新; SHAO, YU-YUN; LIN, ZONG-ZHE; HU, FU-CHANG; YU, CHONG-JEN; SHIH, JIN-YUAN; HU, WEN-YU; CHANG, YIH-LEONG; CHENG, ANN-LII; YANG, PAN-CHYR; YANG, CHIH-HSIN |
| 國立臺灣大學 |
2009 |
A Phase Ii Study of Bibw 2992, a Novel Irreversible Dual Egfr and Her2 Tyrosine Kinase Inhibitor (Tki), in Patients with Adenocarcinoma of the Lung and Activating Egfr Mutations after Failure of One Line of Chemotherapy (Lux-Lung 2)
|
楊志新; YANG, CHIH-HSIN |
| 國立臺灣大學 |
2009 |
Biomarker Analyses from a Phase Iii, Randomized, Open-Label, First-Line Study of Gefitinib (G) Versus Carboplatin/Paclitaxel (C/P) in Clinically Selected Patients (Pts) with Advanced Non-Small Cell Lung Cancer (Nsclc) in Asia (Ipass)
|
楊志新; YANG, CHIH-HSIN |
| 國立臺灣大學 |
2009 |
Efficacy of Pemetrexed-Cisplatin (Pc) in East Asian Patients (Pts): Subgroup Analysis of a Phase Iii Study Comparing Pc Versus Gemcitabine- Cisplatin (Gc) in First-Line Treatment of Advanced Non-Small Cell Lung Cancer (Nsclc)
|
楊志新; YANG, CHIH-HSIN |
| 國立臺灣大學 |
2009 |
Phase Iib/Iii Double-Blind Randomized Trial of Bibw 2992, an Irreversible, Dual Inhibitor of Egfr and Her2 Plus Best Supportive Care (Bsc) Versus Placebo Plus Bsc in Patients with Nsclc Failing 1-2 Lines of Chemotherapy (Ct) and Erlotinib or Gefitinib (Lu
|
楊志新; YANG, CHIH-HSIN |
| 國立臺灣大學 |
2009 |
Vandetanib Plus Pemetrexed Versus Pemetrexed as Second-Line Therapy in Patients with Advanced Non-Small Cell Lung Cancer (Nsclc): A Randomized, Double-Blind Phase Iii Trial (Zeal)
|
楊志新; YANG, CHIH-HSIN |
| 臺大學術典藏 |
2009 |
First-Line Systemic Treatment of Advanced Stage Non-Small-Cell Lung Cancer in Asia: Consensus Statement from the Asian Oncology Summit 2009
|
楊志新; Soo, Ross A; Anderson, Benjamin O; Cho, Byoung Chul; Yang, Chih-Hsin; Liao, Meilin; Lim, Wan-Teck; Goldstraw, Peter; Mok, Tony S; Soo, Ross A; Anderson, Benjamin O; Cho, Byoung Chul; Yang, Chih-Hsin; Liao, Meilin; Lim, Wan-Teck; Goldstraw, Peter; Mok, Tony S |
| 國立臺灣大學 |
2008-11 |
Effects of activating epidermal growth factor receptor mutations on clinical response
|
Gow, Chien-Hung; Chien, Chun-Ru; Chang, Yih-Leong; Chiu, Yueh-Hsai; Kuo, Sung-Hsin; Shih, Jin-Yuan; Chang, Yeun-Chung; Yu, Chong-Jen; Yang, Chih-Hsin; Yang, Pan-Chyr |
| 國立成功大學 |
2008-10 |
High efficacy of erlotinib in Taiwanese NSCLC patients in an expanded access program study previously treated with chemotherapy
|
Perng, Reury-Perng; Yang, Chih-Hsin; Chen, Yuh-Min; Chang, Gee-Chen; Lin, Meng-Chih; Hsieh, Ruey-Kuen; Chu, Nei-Min; Lai, Ruay-Sheng; Su, Wu-Chou; Tsao, Chao-Jung; Hsia, Te-Chun; Chen, Hao-Cheng; Chen, Chih-Hung; Huang, Ming-Shyan; Wang, Jui-Long; Ho, Ming-Lin; Chung, Chih-Yuan; Yu, Chong-Jen; Chang, Wen-Cheng; Kuo, Han-Pin; Yu, Chih-Teng; Lin, Zhong-Zhe; Kao, Woei-Yau |
| 國立臺灣大學 |
2008-06 |
Outcome of advanced nonsmall cell lung cancer patients receiving gemcitabine and weekly paclitaxel as first-line treatment
|
Lin, Zhong-Zhe; Hsu, Chiun; Chang, Yeun-Chung; Yu, Chong-Jen; Hsu, Chih-Hung; Lin, Chia-Chi; Cheng, Ann-Lii; Yang, Pan-Chyr; Yang, Chih-Hsin; 林宗哲; 許駿; 張允中; 余忠仁; 徐志宏; 林家齊; 鄭安理; 楊泮池; 楊志新 |
| 國立臺灣大學 |
2008-01 |
Radiotherapy in Lung Adenocarcinoma with Brain Metastases: Effects of Activating Epidermal Growth Factor Receptor Mutations on Clinical Response
|
Gow, Chien-Hung; Chien, Chun-Ru; Chang, Yih-Leong; Chiu, Yueh-Hsia; Kuo, Sung-Hsin; Shih, Jin-Yuan; Chang, Yeun-Chung; Yu, Chong-Jen; Yang, Chih-Hsin; Yang, Pan-Chyr; 高劍虹; 簡君儒; 張逸良; 邱月瑕; 郭頌鑫; 施金元; 張允中; 余忠仁; 楊志新; 楊泮池 |
| 國立臺灣大學 |
2008-01 |
Specific EGFR mutations predict treatment outcome of stage IIIB/IV patients with chemonaive NSCLC patients receiving first-line gefitinib monotherapy
|
Yang, Chih-Hsin; Yu, Chong-Jen; Shih, Jin-Yuan; Chang, Yeun-Chung; Hu, Fu-Chang; Tsai, Meng-Chin; Chen, Kuan-Yu; Lin, Zhong-Zhe; Huang, Ching-Ju; Shun, Chia-Tung; Huang, Chin-Lun; Bean, James; Cheng, Ann-Lii; Pao, William; Yang, Pan-Chyr |
Showing items 41-65 of 115 (5 Page(s) Totally)
<< < 1 2 3 4 5 > >>
View [10|25|50] records per page
|
